Combination of Autophagy Selective Therapeutics With Doxil: An Assessment of Pathological Toxicity

Background: Combination therapy of targeted drugs in cancer treatment is a field in constant flux, with research balancing side effects with efficacy. Efficacy from combination therapy is improved either through synthetic lethality or through prevention of recurrent clones. Previous research has sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Helke, Kristi L., Gudi, Radhika R., Vasu, Chenthamarakshan, Delaney, Joe R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276957/
https://www.ncbi.nlm.nih.gov/pubmed/35846434
http://dx.doi.org/10.3389/ftox.2022.937150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276957/
https://www.ncbi.nlm.nih.gov/pubmed/35846434
http://dx.doi.org/10.3389/ftox.2022.937150

Ejemplares similares